| Offering Information |
| Expected Date | WITHDRAWN |
| Proposed Exchange/Ticker |
OTC BB: CTI |
| Security Type |
Common Stock |
| Lead Underwriter |
GMP Securities Ltd. |
| Days In Registration |
188 |
| Date Filed |
30-May-2007 |
| Form Filed | S-B2 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Manufacturing |
| Business Description |
Chemokine Therapeutics Corp, located in Vancouver, Canada, is a biotechnology company engaged in developing drugs out of stem cells through chemokine pathways. The company was incorporated in the State of Washington on July 15, 1998 as PTM Molecular Biosystems Inc. and in 1999 the compnay's name was changed to Chemokine Therapeutics Corp. In 2000, the company was reincorporated in the State of Delaware. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
88.68M |
| Contact |
- |
| Number of Employees |
20 |
|
| Original Filing Information |
| US |
| Shares Filed |
46.5M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
6975.0K |
| File Amount |
- |
| File Price Range |
$0.55 - $0.55 |
| File Mid Price |
$0.55 |
|
